Inhibitor Therapeutics, Inc. (INTI)

USD 0.07

(14.55%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue - - - - - -
Gross Profit - - - - - -
Operating Expenses 3.4 Million 657.92 Thousand 325.39 Thousand 1.05 Million 2.74 Million 4.56 Million
Selling, General and Administrative Expenses 2.02 Million 651.77 Thousand 320.49 Thousand 873.7 Thousand 1.53 Million 1.93 Million
Research and Development Expenses 1.38 Million 6150.00 4905.00 185.29 Thousand 1.2 Million 2.63 Million
Other Expenses - - - - - -
Cost and Expenses 3.4 Million 657.92 Thousand 325.39 Thousand 1.05 Million 2.74 Million 4.56 Million
Operating Income -3.4 Million -657.92 Thousand -325.39 Thousand -1.05 Million -2.74 Million -4.56 Million
Interest Expense - 23.23 Thousand 14.83 Thousand - - -
Income Tax Expense - 55.1 Thousand 14.83 Thousand -1068.00 -14.54 Thousand -14.02 Thousand
Earnings before Tax -3.02 Million 12.16 Million -298.63 Thousand -1.05 Million -2.73 Million -4.55 Million
Net Income -3.02 Million 12.1 Million -313.46 Thousand -1.05 Million -2.71 Million -4.55 Million
Earnings Per Share Basic -0.02 0.03 -0.00 -0.00 -0.01 -0.01
Earnings Per Share Diluted -0.02 0.03 -0.00 -0.00 -0.01 -0.01
Weighted Average Shares Outstanding 151.31 Million 366.18 Million 376.24 Million 371.92 Million 370.43 Million 369.81 Million
Weighted Average Shares Outstanding (Diluted) 171.95 Million 367.77 Million 376.24 Million 371.92 Million 370.43 Million 369.81 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA 378.84 Thousand -657.92 Thousand -325.39 Thousand -1.05 Million -2.74 Million -
Earnings Before Tax Margin - - - - - -

Income Statement Charts